HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 260.65 Thousand AUD | -0.78% |
| 2022 | 262.7 Thousand USD | -94.41% |
| 2021 | 4.7 Million AUD | 1792.94% |
| 2020 | 248.36 Thousand AUD | -27.58% |
| 2019 | 342.95 Thousand AUD | 83.31% |
| 2018 | 187.09 Thousand AUD | -51.71% |
| 2017 | 387.39 Thousand AUD | 29.87% |
| 2016 | 298.3 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | 209.37 Thousand AUD | 0.0% |
| 2023 Q2 | 258.08 Thousand USD | 0.0% |
| 2023 FY | 260.65 Thousand AUD | -0.78% |
| 2022 Q4 | 262.7 Thousand USD | 0.0% |
| 2022 FY | 262.7 Thousand USD | -94.41% |
| 2022 Q2 | 254.91 Thousand USD | 0.0% |
| 2021 Q4 | 4.7 Million AUD | 0.0% |
| 2021 Q2 | 247.4 Thousand USD | 0.0% |
| 2021 FY | 4.7 Million AUD | 1792.94% |
| 2020 Q2 | 246.58 Thousand USD | 0.0% |
| 2020 Q4 | 248.36 Thousand AUD | 0.0% |
| 2020 FY | 248.36 Thousand AUD | -27.58% |
| 2019 Q4 | 342.95 Thousand AUD | 0.0% |
| 2019 FY | 342.95 Thousand AUD | 83.31% |
| 2019 Q2 | 230.61 Thousand USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | 187.09 Thousand AUD | -51.71% |
| 2018 Q4 | 223.2 Thousand USD | 0.0% |
| 2017 Q4 | 389.02 Thousand USD | 0.0% |
| 2017 FY | 387.39 Thousand AUD | 29.87% |
| 2016 FY | 298.3 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 94.91% |
| Adherium Limited | 93.2 Thousand AUD | -179.659% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 96.176% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -207.849% |
| Anteris Technologies Ltd | 2.33 Million AUD | 88.827% |
| Control Bionics Limited | 961.73 Thousand AUD | 72.897% |
| CardieX Limited | 3.22 Million AUD | 91.925% |
| Compumedics Limited | 6.97 Million AUD | 96.264% |
| Cochlear Limited | 243.7 Million AUD | 99.893% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 92.437% |
| Cyclopharm Limited | 4.22 Million AUD | 93.834% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 91.013% |
| Nova Eye Medical Limited | 3.34 Million AUD | 92.217% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 98.34% |
| ImpediMed Limited | 1.14 Million AUD | 77.195% |
| InhaleRx Limited | 560.27 Thousand AUD | 53.477% |
| LBT Innovations Limited | 1.74 Million AUD | 85.046% |
| Micro-X Limited | 4.05 Million AUD | 93.572% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -268.825% |
| PolyNovo Limited | 15.38 Million AUD | 98.305% |
| Respiri Limited | 1.17 Million AUD | 77.846% |
| SomnoMed Limited | 1.01 Million AUD | 74.345% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 94.757% |
| Uscom Limited | 989.27 Thousand AUD | 73.652% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | 16.498% |